Mentions
Extended reach
Total likes
Video views
AI synopsis
The group's discussions reflect strong agreement on the article's importance, with many references to specific studies by Munster and Koopmans, citing their published papers and their roles in influential research. The tone suggests high interest and deep engagement, as exemplified by questions about virus mechanisms, scientific collaborations, and implications for pandemic preparedness, illustrating the article’s significant impact on ongoing scientific and public health debates.
Most discussions acknowledge the thoroughness and importance of the article, emphasizing the need for impact assessment and early response.
Posts demonstrate high curiosity, frequently referencing detailed scientific findings and the significance of early detection.
Participants engage deeply, asking technical questions about virus characteristics, referencing multiple research papers, and discussing implications.
The collective tone underscores the article’s high influence on understanding virus transmission, scientific collaboration, and public health strategies.
A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted 22 jan and published 24 jan 2020 https://t.co/66gX6hI2SC This is the paper on which list A is based! around the world... co-author Marion Koopmans. https://t.co/pzWelSIMli
https://t.co/qE1qfgT8fN Also, it matters where an outbreak occurs, who are affected, what their underlying health issues are. So statements like this (100x higher lethality) are really not supported scientifically.
@MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het driehoekje van v Dissel tegen. Dat heeft hij dus goed overgenomen. Dit allemaal nog voor de brief va Bruins voor de lijst A additie, je zou bijna denken dat deze paper het startschot was. https://t.co/FghDAf5L1j
@Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedia) Marion Koopmans is sinds 2013 Hoofd afdeling Viroscience op het Erasmus MC. Ook begin 2020 behoorde ze tot de directe werking van Marion Koopmans: https://t.co/LYEVbZSfV4
@jhas5 So, Rocky Mountains Munster. Remember the january 2020 paper by Munster and Koopmans et. al.? Look at the last sentence: "If we are proactive in these ways, perhaps we will never have to discover the true epidemic or pandemic potential of 2019-nCoV." https://t.co/fgbeVtGtot
@ArmandGirbes @E_line @irahelsloot Dat zijn voornamelijk argumenten dat aan het begin van een uitbraak de CFR moeilijk te schatten is. Dat is bekend en uiteraard besproken. Ik begrijp niet waarom je doet alsof alleen jullie dat inzicht hadden. Zie bijvoorbeeld https://t.co/lLupqPeL1U
This video explores how long SARS-CoV-2 can survive in aerosols and on surfaces compared to SARS-CoV-1. Understanding these patterns is crucial for public health measures and controlling the spread of the virus.
This video provides the latest updates on the survival of SARS-CoV-2 in air and on surfaces, comparing it to SARS-CoV-1. Learn how this impacts transmission and public health measures. Stay informed and ensure you're…
This animated video explains how to prevent the spread of COVID-19. We highlight the duration SARS-CoV-2 remains infectious in the air and on surfaces compared to SARS-CoV-1, which is vital for public health strategies.
The coronavirus disease 2019 (COVID-19) has spread globally, leading to numerous fatalities. This study provides an epidemiological overview and clinical characteristics of 165 confirmed COVID-19 patients in Fujian…
This video addresses the emergence of a new coronavirus in China, highlighting its potential impact on global health, virus transmission, severity, and effectiveness of current health measures. Early assessment and…
This video explains what coronavirus is, how it infects humans, and its potential impact on global health. It covers virus transmission, severity, and measures to prevent widespread outbreaks, emphasizing early response…
It's time to act, and this animated video explains what we need to do to prevent further infections. Stay prepared and informed with our real-time data links and scientific references on Covid-19.
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | By Munster / Koopmans @jhas5 Thus, disease severity is not necessarily linked to transmission efficiency https://t.co/HhT30vxdSb
RT @Rozemar79838305: Vincent Munster, a NL scientist, from Rocky Mountains lab, is specifically mentioned in a new request for info by @Sen…
Vincent Munster, a NL scientist, from Rocky Mountains lab, is specifically mentioned in a new request for info by @SenRandPaul. Jan. 24 2020 Munster published in NEJM with Koopmans, praising China and WHO. We now know about WHO's umbrella (Farrar) https://t.co/eRkNXADlDv https://t.co/LVhgRh6w8v https://t.co/yKY0D6bdIw
RT @petelincoln48: Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before Ch…
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
RT @jhas5: @Rebecca21951651 @Rozemar79838305 @AphidPete This was type of paper Marion (& Montana) wanted https://t.co/TsHvub7lQ6 https://t…
@ArmandGirbes @E_line @irahelsloot Dat zijn voornamelijk argumenten dat aan het begin van een uitbraak de CFR moeilijk te schatten is. Dat is bekend en uiteraard besproken. Ik begrijp niet waarom je doet alsof alleen jullie dat inzicht hadden. Zie bijvoorbeeld https://t.co/lLupqPeL1U
(PDF) A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment Munster de Wit Koopmans https://t.co/4f25ccCOYw
RT @MarionKoopmans: https://t.co/qE1qfgT8fN Also, it matters where an outbreak occurs, who are affected, what their underlying health issue…
RT @MarionKoopmans: https://t.co/qE1qfgT8fN Also, it matters where an outbreak occurs, who are affected, what their underlying health issue…
https://t.co/qE1qfgT8fN Also, it matters where an outbreak occurs, who are affected, what their underlying health issues are. So statements like this (100x higher lethality) are really not supported scientifically.
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
@Bryce_Nickels Ask @MarionKoopmans why she missed the SARS2 furin cleavage site in this Vincent Munster paper? https://t.co/kEZP6QEP7M
RT @Rozemar79838305: @jhas5 So, Rocky Mountains Munster. Remember the january 2020 paper by Munster and Koopmans et. al.? Look at the last…
RT @petelincoln48: Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before Ch…
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
RT @Gijzen_Willem: @Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedi…
@Denachtzuster1 Emmie de Wit komt uit Nederland. Ze behaalde haar Ph.D. in virologie in 2006 op het Erasmus MC (Wikipedia) Marion Koopmans is sinds 2013 Hoofd afdeling Viroscience op het Erasmus MC. Ook begin 2020 behoorde ze tot de directe werking van Marion Koopmans: https://t.co/LYEVbZSfV4
10/The other paper published in the NEJM 2 days later, hypothesized that a Pandemic Virus had to be not overly pathogenic in order to spread widely, as these relatively low path viruses could not be contained with traditional containment measures,…. https://t.co/lYsntew8rK
If its 50% fatal it wont spread much. Its viruses that have milder symptoms that spread most rapidly https://t.co/lYsntew8rK https://t.co/0TFzJ7D5BV
RT @petelincoln48: Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before Ch…
RT @petelincoln48: Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before Ch…
RT @petelincoln48: Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before Ch…
Moderna had the sequence for their vaccine mRNA done on January 12th, and both Moderna had a vaccine developed before China. Vincent Munster had a paper published that suggested knowledge of the sequence before Jan 11 https://t.co/lYsntew8rK https://t.co/MrSFghVunw
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | New England Journal of Medicine #koopmans #emmydewit 2020 https://t.co/HhT30vxdSb
https://t.co/l4banDEe9X
@P_McCulloughMD @NIH @BARDA https://t.co/l4banDEe9X
@I_Am_JohnCullen https://t.co/l4banDEe9X
RT @Rozemar79838305: @jhas5 So, Rocky Mountains Munster. Remember the january 2020 paper by Munster and Koopmans et. al.? Look at the last…
RT @Rozemar79838305: @jhas5 So, Rocky Mountains Munster. Remember the january 2020 paper by Munster and Koopmans et. al.? Look at the last…
@jhas5 So, Rocky Mountains Munster. Remember the january 2020 paper by Munster and Koopmans et. al.? Look at the last sentence: "If we are proactive in these ways, perhaps we will never have to discover the true epidemic or pandemic potential of 2019-nCoV." https://t.co/fgbeVtGtot
RT @AlleBurgers: ‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-l…
RT @AlleBurgers: @R_H_Ebright Feldmann; Montana AND Winnipeg!? @jhas5 NL/GER Connections, everywhere.
RT @AlleBurgers: @R_H_Ebright Feldmann; Montana AND Winnipeg!? @jhas5 NL/GER Connections, everywhere.
@R_H_Ebright Feldmann; Montana AND Winnipeg!? @jhas5 NL/GER Connections, everywhere.
@MarionKoopmans You were a co-author with Vinnie on this Feb 2020 paper, but no mention of his furin cleavage site? https://t.co/sQeAXclaGY
RT @AlleBurgers: ‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-l…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM #munster @jhas5 https://t.co/PiT8jcjxtS
RT @macharoesink: via .@AlleBurgers Coronavirus Emerging in China Key Questions Impact Assessment Waarom koos #OMT niet voor #indammen #…
RT @macharoesink: via .@AlleBurgers Coronavirus Emerging in China Key Questions Impact Assessment Waarom koos #OMT niet voor #indammen #…
RT @macharoesink: via .@AlleBurgers Coronavirus Emerging in China Key Questions Impact Assessment Waarom koos #OMT niet voor #indammen #…
RT @macharoesink: #OldActualNews Feb 2020 A Coronavirus Emerging in China Key Questions for Impact Assessment previous outbreaks contained…
RT @AlleBurgers: ‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-l…
RT @AlleBurgers: ‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-l…
via .@AlleBurgers Coronavirus Emerging in China Key Questions Impact Assessment Waarom koos #OMT niet voor #indammen #containment terwijl risico ziekenhuizen & verpleeghuizen al in feb 2020 onderkend? .@MarionKoopmans .@Ipie33 https://t.co/iNhVxXqeAM
#OldActualNews Feb 2020 A Coronavirus Emerging in China Key Questions for Impact Assessment previous outbreaks contained through identification of cases &tracing of contacts, despite virus’s efficient person-to-person transmission .@AlleBurgers https://t.co/iNhVxXqeAM
RT @AlleBurgers: ‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-l…
‼️DUTCH WUHAN CONNECTION. Big (serial passage?) role of Erasmus in EcoHealth/Wuhan DEFUSE project? ➡️Munster (NIH/Fauci-lab), protégé Erasmus Fouchier, pre-published with Marion Koopmans cs Jan20 on Covid/*airborne* characteristics. https://t.co/qMeqXDWa1y Ht @Rebecca21951651 https://t.co/pFSqFOiZ2R https://t.co/1VTSAPp1k6
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/HhT30vxdSb
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/mXfwvqRlVG
RT @jhas5: @Rebecca21951651 @Rozemar79838305 @AphidPete This was type of paper Marion (& Montana) wanted https://t.co/TsHvub7lQ6 https://t…
RT @jhas5: @Rebecca21951651 @Rozemar79838305 @AphidPete This was type of paper Marion (& Montana) wanted https://t.co/TsHvub7lQ6 https://t…
@Rebecca21951651 @Rozemar79838305 @AphidPete This was type of paper Marion (& Montana) wanted https://t.co/TsHvub7lQ6 https://t.co/TwUn934SL1
RT @jhas5: @dorkmo @Bryce_Nickels @MarionKoopmans & ask Marion why her & Munster missed the FCS? https://t.co/TsHvub6O0y
@dorkmo @Bryce_Nickels @MarionKoopmans & ask Marion why her & Munster missed the FCS? https://t.co/TsHvub6O0y
RT @jhas5: @BillyBostickson Munster went to Erasmus & published Feb 2020 with Marion https://t.co/oYhB0AMvA7 https://t.co/TsHvub6O0y
RT @AlleBurgers: ‼️Montana Lab Fauci experimenteerde misschien al één jaar vóór de pandemie met coronavirussen⤵️ Nederlander Munster is on…
RT @AlleBurgers: ‼️Montana Lab Fauci experimenteerde misschien al één jaar vóór de pandemie met coronavirussen⤵️ Nederlander Munster is on…
RT @AlleBurgers: ‼️Montana Lab Fauci experimenteerde misschien al één jaar vóór de pandemie met coronavirussen⤵️ Nederlander Munster is on…
RT @AlleBurgers: ‼️Montana Lab Fauci experimenteerde misschien al één jaar vóór de pandemie met coronavirussen⤵️ Nederlander Munster is on…
‼️Montana Lab Fauci experimenteerde misschien al één jaar vóór de pandemie met coronavirussen⤵️ Nederlander Munster is onderzoeksleider. Komt van Erasmus MC, beschermeling Fouchier. ➡️ Munster publiceert met Marion Koopmans op 24 jan 2020‼️ https://t.co/qMeqXDWa1y https://t.co/RDjvVDpSWA https://t.co/qN1D7kEGnH
@WooHooQi @R_H_Ebright @DrTedros Date & Authors https://t.co/mXfwvqRlVG
RT @Rozemar79838305: @virologyanon @humourme101 @Biorealism @MarionKoopmans Bart Haagmans was on the 10-02-2020 Lancet paper. Of interest a…
@ContainmentNu ‼️Read this one
RT @Rozemar79838305: @virologyanon @humourme101 @Biorealism @MarionKoopmans Bart Haagmans was on the 10-02-2020 Lancet paper. Of interest a…
@virologyanon @humourme101 @Biorealism @MarionKoopmans Bart Haagmans was on the 10-02-2020 Lancet paper. Of interest are the Dutch scientists who work at the NIH with Erasmus lab roots: Vincent J Munster and Emmie de Wit. Published early 2020 with Koopmans. Neeltje van Doremalen has no Erasmus roots.
RT @Rozemar79838305: @BenthemJoost @Rebecca21951651 @MarkAlbano9 @TheSeeker268 @Magda_Skipper @MarionKoopmans @JamesCTobias There are also…
@BenthemJoost @Rebecca21951651 @MarkAlbano9 @TheSeeker268 @Magda_Skipper @MarionKoopmans @JamesCTobias There are also scientists from the Netherlands who work at NIH. NIH also funds Erasmus according to Koopmans. Could that be a possibility? E.g. https://t.co/fgbeVtGtot
@sambadouro ということは、「https://t.co/CEoKBrAe7t の論文は、新型ウイルス以外のものも取っていて、実際には分離できていないのに、分離したという嘘の報告をしている」というご主張なのですね？ では、どこから切り取ったのか良くわからない画像以外に、その主張を裏付ける情報、データなどはありますか？
Re disease pyramid: this is the distribution of asymptomatic, mild, severe and lethal infections. Always difficult to determine, in humans let alone wild animals. https://t.co/qE1qfgT8fN
RT @jhas5: Covid's creator, Vincent Munster, makes an appearance! pimping this "animal market" article with @MarionKoopmans https://t.co…
RT @jhas5: Covid's creator, Vincent Munster, makes an appearance! pimping this "animal market" article with @MarionKoopmans https://t.co…
Covid's creator, Vincent Munster, makes an appearance! pimping this "animal market" article with @MarionKoopmans https://t.co/TsHvub6O0y https://t.co/nETS4WE6wD
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment https://t.co/LFaUE0pqIV
@MarionKoopmans @Ayjchan @NatureMedicine @K_G_Andersen So u didn’t mention FCS in ur Munster paper? https://t.co/TsHvub6O0y & why is NA wt deer the reservoir? https://t.co/yMdPSNHzOs
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
@mkeulemans @MarkvLoosdrecht @MarcBonten @AlmaTostmann Ware het niet dat clinici daar nu net niet goed in zijn. Het gaat nl niet over individuele patient maar om verdeling van de pyramide. Ondanks pleidooi van oa RIVM al jaren is er ook geen realtime surveillance van trends in ziekenhuisopnames. https://t.co/qE1qfgT8fN op de to do
@Rad__knight @SuperSpacedad @damenreich No, not accurately. I’ve already explained why. Also cite your figures. The flu & COVID-19 simply don’t have comparable case fatality rates. https://t.co/z0U5i1PmZp ; https://t.co/IEVmoxYewg
@jrmy_tu @BadCOVID19Takes The symptoms of #COVID19 are not specific To accurately diagnose respiratory infections, a diagnostic test to detect the causative organism is necessary SARS (#1) was pretty scary with 10-15% death rate & MERS at 30-35% https://t.co/Tnd7xUDO6P #COVID19 #VaccinesSaveLives https://t.co/DSDucYUPVV
RT @AmeshAA: "2 coronaviruses that use the same receptor (ACE2) — NL63 and SARS-CoV — cause disease of different severity" -- important poi…
RT @jhas5: @BillyBostickson Munster went to Erasmus & published Feb 2020 with Marion https://t.co/oYhB0AMvA7 https://t.co/TsHvub6O0y
@BillyBostickson Munster went to Erasmus & published Feb 2020 with Marion https://t.co/oYhB0AMvA7 https://t.co/TsHvub6O0y
RT @dancalegria: @MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het dri…
RT @dancalegria: @MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het dri…
RT @dancalegria: @MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het dri…
RT @dancalegria: @MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het dri…
@MarionKoopmans @DeTelegraaf_MUN Deze publicatie moet je je toch herinneren. https://t.co/bqfkatHUNa Daar komen we het driehoekje van v Dissel tegen. Dat heeft hij dus goed overgenomen. Dit allemaal nog voor de brief va Bruins voor de lijst A additie, je zou bijna denken dat deze paper het startschot was. https://t.co/FghDAf5L1j
@jhas5 Munster is de specialist die voor Fauci werkt. Er zitten daar heel veel Nederlanders. Koopmans heeft 5 jaar voor het CDC gewerkt, Fouchier ook een jaartje. https://t.co/XnlEs2OcAO https://t.co/hXf8CCZY5j https://t.co/4hnSPvi6lh https://t.co/bqfkatHUNa https://t.co/7wUInmH9eo
@YorickB @ginnymooy @FSchaapherder @loekalization @edwinveldhuizen @jacvre @rki_de https://t.co/lLupqPeL1U
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
@MarionKoopmans @AlmaTostmann @TijsvandenBrink Ik schuif graag aan. Waar spreken we af? Moeten we van te voren nog wat doornemen? https://t.co/iIPGafpAUy Kunnen we al deze auteurs uitnodigen?
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: @DevliegerErik @MarionKoopmans Het net sluit zich. Vooral deze publicatie blijkt een nagel aan de bekende kist. https://t.…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
RT @dancalegria: A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted…
A bit more about Vincent Munster. Again a publication in 3 days! like the PCR paper(21-23 jan 2020) In this case submitted 22 jan and published 24 jan 2020 https://t.co/66gX6hI2SC This is the paper on which list A is based! around the world... co-author Marion Koopmans. https://t.co/pzWelSIMli
@MarionKoopmans Misschien is iedereen wel benieuwd wat er van NL63 terecht is gekomen? N. Engl. J. Med. 2020;382-:692–694. doi: 10.1056/NEJMp2000929 Hier beweer je toch feitelijk dat NL63 nog steeds onder de mens is, feitelijk bestaat #NL63 bij gratie van enkelen die ons weinig gemeld hebben?? https://t.co/dIwjfoUNgm
@pgcornwell Some of us knew because we read NEJM https://t.co/wH4WuRXDec
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment [Jan 24, 2020] Munster et al. @NEJM https://t.co/SWkF99dl8X #2019nCoV Much of our thinking... has been influenced by our understanding of influenza A virus
@spidertje @bslagter @mauricedehond @MarkvLoosdrecht Je moet denken in termen van een pyramide. De vraag is welk deel van de positieven een huisarts raadpleegt. Stel dat is 2% . Dat zie je niet in de totale bezoeken, en is toeval of ze net wel bij een peilstation komen. Zagen we ook in 2009. Zie ook dit https://t.co/jB0f1dRv4A
@jeg_28 @deborah91473 My condolences for your loss, but blaming a Pres 4 a death? Roosevelt is the reason people died at Pearl Harbor? PPL r by nature lazy-NEJM https://t.co/7LqXq6iZMh do they know,right? #bebetter#dontbesheep#notaboutpoliticalparties. Grieving=wanting to blame
RT @MarionKoopmans: https://t.co/BNJqSEcHbK as argued here https://t.co/jB0f1dRv4A
RT @MarionKoopmans: https://t.co/BNJqSEcHbK as argued here https://t.co/jB0f1dRv4A
RT @MarionKoopmans: https://t.co/BNJqSEcHbK as argued here https://t.co/jB0f1dRv4A
@magnusllewellin Unaware? 24th Jan: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/mXpiyboE8C "Thus, emerging viruses that may go undetected because of a lack of severe disease in healthy people can pose significant risk to vulnerable populations."
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM This possibility warrants current aggressive response aimed at tracing & diagnosing every infected patient-thereby breaking transmission chain: 2019-nCoV #COVID19 #SARSCoV2 https://t.co/sqy9kRecUg
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment [Jan 24, 2020] Munster et al. @NEJM https://t.co/SWkF99dl8X #2019nCoV Much of our thinking... has been influenced by our understanding of influenza A virus
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment [Jan 24, 2020] Munster et al. @NEJM https://t.co/SWkF99uW0v #2019nCoV Much of our thinking... has been influenced by our understanding of influenza A virus
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/W6t1pdmU32
Putting things in perspective. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/78AlMQ2H6C
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/gE1kWsh33k
RT @AngelPSempere: Para los interesados en el virus de moda, el coronavirus que viene de Oriente. A Novel Coronavirus Emerging in China — K…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/xcJTBYvUZg
A scholarly, highly reliable review of #coronavirus in New England Journal form the National Institutes of Health, USA. @UofT_dlsph @PublicHealthON @picardonhealth A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/xymeCYIKNA
RT @DebbyvanRiel: Check out our perspective on key question for impact assesment of the 2019-nCoV in NEJM. @DrNeeltje @MarionKoopmans @Eras…
RT @DrPalencia: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/nBOyOjFjbM
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/gZrZuJ1uM4 https://t.co/zfUoSs2E1F
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/nBOyOjFjbM
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment by @NEJM. A nice article to understand what we should ask. https://t.co/lEYiiTNCoj
RT @acinantioquia: Este artículo pone en el contexto de otros virus respiratorios a COVID-19, está muy recomendado. A Novel Coronavirus Eme…
Este artículo pone en el contexto de otros virus respiratorios a COVID-19, está muy recomendado. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/NzyPkGkQ9n
RT @GlobalVirusNews: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment: https://t.co/VmKMQSCri9 @WHO #coronarviru…
RT @carpe_diem0820: 現時点で2019-nCoV感染症はSARSおよびMERSと比較して比較的重症度が低いと考えられる（SARSの致命率11%) super-spreaderを含めた、院内感染対策が重要（エアロゾル発生時等） 大規模感染も想定 A Novel…
RT @SusannaEsposit1: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/KDuKfPAy3t
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/KDuKfPAy3t
RT @vic_pallares: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/51wrHBNXs1
RT @ernestocardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/VHLLHaoGaT @mencardio @c…
RT @vic_pallares: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/51wrHBNXs1
RT @vic_pallares: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/51wrHBNXs1
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/51wrHBNXs1
RT @ernestocardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/VHLLHaoGaT @mencardio @c…
RT @ernestocardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/VHLLHaoGaT @mencardio @c…
RT @ernestocardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/VHLLHaoGaT @mencardio @c…
RT @DebbyvanRiel: Check out our perspective on key question for impact assesment of the 2019-nCoV in NEJM. @DrNeeltje @MarionKoopmans @Eras…
RT @mayogastro: Muy buen artículo. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/iaDBgz57…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/kHrPSLs8BG https://t.co/l3IvzIlrwV
SALUD PÚBLICA - Munster et al - A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment . https://t.co/N2qiDRF2Ts
RT @mencardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/kOZF4yQv4D vía @torresviera…
Aquí se explica claramente que, a pesar del esfuerzo es muy difícil contener estas epidemias. La Argentina debe prepararse. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/sZsuDyy5T6
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/CGYFpKTK92
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/EoBUp3yw8F
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/fKoMiHABcv
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM #ISCIII #WuhanCoronovirus #publichealth #epidemic #WuhanCoronovirus #nCoV2019 https://t.co/eRBu0aPVAz
RT @kimitakatajimi: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/LLdqVLjXcd
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/LLdqVLjXcd
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/uKKZ0j9Qgq
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/oHtyu7UcG9
RT @teachepi: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/WAlOPPnV21
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/z4xLy8rNvI https://t.co/MyuiQr6xJT
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/7JM9GUHUnT
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/kWoJMP7bUE
Great questions and some answers. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/xh5YrsurqL
RT @mayogastro: Muy buen artículo. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/iaDBgz57…
RT @mayogastro: Muy buen artículo. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/iaDBgz57…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/6BsECrtnpU
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment. https://t.co/0j7HCgLsob
Muy buen artículo. A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/iaDBgz57Fg
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/Cyv7pvcZHO
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/pUXCecbmzX @CardiologiaSVC @SVMI_Nacional
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/jKvoqgWHEL
RT @profdrbarisakin: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/Cmc0v2P51q
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/AR2jjLGBOn
RT @DerryIcu: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM impact assessment #coronavirus #FOAMed ht…
@AzulPromedio @DonReclamon A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/Fr3miwiCou
RT @McDonado_: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/34ZmKA80S5
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/34ZmKA80S5
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM impact assessment #coronavirus #FOAMed https://t.co/E8o3Zlj1oC
RT @profdrbarisakin: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/Cmc0v2P51q
RT @ECMOdaily: A Novel #Coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/hmOsaaO4gN @NEJM and Brief Report…
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/coWbpVya6x
RT @marciasgreen: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/wHrHxL1HBe
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/wHrHxL1HBe
Trend up+1: *Munster VJ* et al (N Engl J Med) __A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment__ https://t.co/uls7pfYeLa
Munster, V. J., Koopmans, M., Doremalen, N. V., Riel, D. V., & Wit, E. D. (2020). A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment. <i>New England Journal of Medicine.</i> doi: 10.1056/nejmp2000929
A Novel #Coronavirus Emerging in #China — Key Questions for #Impact Assessment | #NEJM https://t.co/ESuanuPYqX from @NEJM #openaccess #CoronaOutbreak
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/iOkScDqeug
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/36rLHZjFmK
RT @mencardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/kOZF4yQv4D vía @torresviera…
RT @GlobalVirusNews: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment: https://t.co/VmKMQSCri9 @WHO #coronarviru…
A Novel #Coronavirus Emerging in #China — Key Questions for Impact Assessment | NEJM https://t.co/FpixfRtVkt
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment: https://t.co/VmKMQSCri9 @WHO #coronarvirus #CoronavirusOutbreak
RT @OlivaLopezA: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/ldHYp12M53
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/hWTuOPNS5o
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment [Jan 24, 2020] Munster et al. @NEJM https://t.co/SWkF99dl8X #2019-nCoV Much of our thinking... has been influenced by our understanding of influenza A virus
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment [Jan 24, 2020] Munster et al. @NEJM https://t.co/SWkF99dl8X #2019nCoV
melhor previnir do que se apavorar A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/kCP3aVdObD
RT @ernestocardio: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/VHLLHaoGaT @mencardio @c…
A Novel #coronavirus Emerging in China — Key Questions for Impact Assessment https://t.co/dL84k1Kj9F
RT @OlivaLopezA: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/ldHYp12M53
RT @AalishaSahukhan: A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment | NEJM https://t.co/B6OWA5S7iD
nCoV-2019は今後どのような感染症として社会にインパクトを及ぼすかのPerspective． 重症患者の割合が多いほど暴露者の追跡による封じ込めがしやすい，軽症が多いほど封じ込めは困難． さてインフルエンザとSARS/MERSの間のどこらへんに落ち着くのか． NEJM https://t.co/i2x8ik8n6Z
AL
VN